Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance ...

New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods ...

Most patients with ovarian cancer are diagnosed at late stage as symptoms at early stages are minimal making it difficult to differentiate from common diseases. Once patients reach these late stages, ...

Clinical research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) continues to ...

Compugen (CGEN) has released an update. Compugen Ltd. has announced promising data on the anti-tumor activity and safety of its triple ...

Dr. Shannon Westin (Host), Dr. Brian Slomovitz (Guest) Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article “Pembrolizumab ... from endometrial cancer is going to outnumber the ...

Keytruda (pembrolizumab) is a prescription drug ... Does Keytruda treat ovarian cancer or brain cancer such as glioblastoma? Currently, Keytruda isn’t used to treat ovarian cancer.

They include Keytruda (pembrolizumab), Opdivo (nivolumab), and others ... a personal history of colorectal or ovarian cancer, large or high-risk adenomas, or a digestive disorder. Treatment for colon ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...